Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009). Cancer statistics, 2009. CA: A Cancer Journal for Clinicians, 59, 225–249.
2. Schmoll, H. J., Van Cutsem, E., Stein, A., Valentini, V., Glimelius, B., Haustermans, K., Nordlinger, B., van de Velde, C. J., Balmana, J., Regula, J., et al. (2012). ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Annals of Oncology, 23, 2479–2516.
3. Zhang, Y., Lin, C., Liao, G., Liu, S., Ding, J., Tang, F., Wang, Z., Liang, X., Li, B., Wei, Y., et al. (2015). MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2. Oncotarget, 6, 32586–32601.
4. Kim, Y. N., Koo, K. H., Sung, J. Y., Yun, U. J., & Kim, H. (2012). Anoikis resistance: An essential prerequisite for tumor metastasis. International Journal of Cell Biology, 2012, 306879.
5. Guadamillas, M. C., Cerezo, A., & Del Pozo, M. A. (2011). Overcoming anoikis–Pathways to anchorage-independent growth in cancer. Journal of Cell Science, 124, 3189–3197.